Fig. 2From: TTK is a potential therapeutic target for cisplatin-resistant ovarian cancerThe up-regulation of TTK in cisplatin-resistant cell line was verified by A western blot and B quantitative real-time PCR compared with parental cells. ***P < 0.001Back to article page